Cardinal Capital Management Inc (North Carolina)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
124,537
+853
+0.7% +$22.3K 0.36% 82
2026
Q1
$3.47M Buy
123,684
+3,455
+3% +$92K 0.45% 75
2025
Q4
$2.99M Buy
+120,229
New +$3.03M 0.4% 79
2025
Q2
Sell
-95,064
Closed -$2.41M 132
2025
Q1
$2.41M Buy
95,064
+5,149
+6% +$135K 0.37% 83
2024
Q4
$2.39M Sell
89,915
-2,591
-3% -$70.3K 0.37% 82
2024
Q3
$2.68M Buy
92,506
+2,090
+2% +$61K 0.42% 76
2024
Q2
$2.53M Buy
90,416
+1,605
+2% +$44.2K 0.43% 73
2024
Q1
$2.46M Buy
88,811
+10,863
+14% +$301K 0.4% 78
2023
Q4
$2.24M Buy
77,948
+47,619
+157% +$1.44M 0.42% 73
2023
Q3
$1.01M Buy
30,329
+1,185
+4% +$41.9K 0.2% 110
2023
Q2
$1.07M Sell
29,144
-58,801
-67% -$2.29M 0.22% 106
2023
Q1
$3.59M Buy
87,945
+1,679
+2% +$72.5K 0.74% 47
2022
Q4
$4.42M Buy
86,266
+3,065
+4% +$147K 0.94% 41
2022
Q3
$3.64M Buy
83,201
+5,581
+7% +$271K 0.86% 44
2022
Q2
$4.07M Buy
+77,620
New +$3.96M 0.93% 42

Other funds holding PFE

Cardinal Capital Management Inc (North Carolina)'s PFE Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Pfizer (PFE) stake by 0.69% in Q2 2026, buying an estimated $22.3K and bringing the position to 124,537 shares worth $3M. The position accounts for 0.36% of the portfolio, ranked #82.

Cardinal Capital Management Inc (North Carolina) first reported a position in PFE in Q2 2022 and has held it in 15 quarters since. The position peaked at $4.42M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 124,537 shares of Pfizer worth $3M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 853 Pfizer shares in Q2 2026, an estimated $22.3K.
  • Pfizer made up 0.36% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #82 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Pfizer in Q2 2022 and has held it in 15 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s Pfizer position peaked at $4.42M in Q4 2022.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.